International Isotopes Inc (INIS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:International Isotopes Inc (INIS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010998
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International Isotopes Inc (INIS) is a provider of medical teletherapy products. The company offers radioisotope products for cancer therapy, nuclear medicine and industrial processes. It offers cobalt and radiochemical products and nuclear medicine calibration standards. INIS’s cobalt and radiochemical products provides Iodine-131, which is used in different types of chemical, industrial and medically related applications. The company’s nuclear medicine calibration standards offer testing of imaging machines to calibration of patient dose measurement devices. It serves nuclear medicine pharmacies, procedures and device sectors. INIS is headquartered in Idaho Falls, Idaho, the US.

International Isotopes Inc (INIS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International Isotopes Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
International Isotopes Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
International Isotopes Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
International Isotopes Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
International Isotopes Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
International Isotopes Inc, Medical Equipment, Deal Details 10
Equity Offering 10
International Isotopes Raises USD3.4 Million in Private Placement of Series C Preferred Stock 10
Debt Offering 11
International Isotopes Raises USD1 Million in Private Placement of 10% Convertible Debentures Due 2015 11
International Isotopes Completes Private Placement Of 8% Convertible Notes Due 2017 For US$3 Million 12
International Isotopes Inc – Key Competitors 13
International Isotopes Inc – Key Employees 14
International Isotopes Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Nov 15, 2017: International Isotopes Announces Third Quarter And Nine-Month 2017 Financial Results 16
Aug 16, 2017: International Isotopes Announces Financial Results For The Second Quarter And Six Months Ended June 30, 2017 18
May 16, 2017: International Isotopes Announces Financial Results For The First Quarter 2017 20
Mar 31, 2017: International Isotopes Announces 2016 Year End Financial Results 22
Nov 15, 2016: International Isotopes Announces Third Quarter And Nine Months 2016 Financial Results 24
Aug 15, 2016: International Isotopes Announces Second Quarter And Six Months 2016 Financial Results 26
May 17, 2016: International Isotopes Announces First Quarter 2016 Financial Results 28
Mar 28, 2016: International Isotopes Announces 2015 4th Quarter And Year End Financial Results 30
Corporate Communications 32
Sep 06, 2017: International Isotopes Announces Dr. Robert Atcher Has Joined The Company Board of Directors 32
Legal and Regulatory 33
Jun 13, 2016: International Isotopes Announces The U.S. Nuclear Regulatory Commission Has Concluded Its Investigation Of The Company’s August 2015 Radiation Exposure Event And Determined No Civil Penalty Will Be Imposed 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
International Isotopes Inc, Medical Equipment, Key Facts, 2016 2
International Isotopes Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
International Isotopes Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
International Isotopes Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
International Isotopes Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
International Isotopes Inc, Deals By Market, 2011 to YTD 2017 8
International Isotopes Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
International Isotopes Raises USD3.4 Million in Private Placement of Series C Preferred Stock 10
International Isotopes Raises USD1 Million in Private Placement of 10% Convertible Debentures Due 2015 11
International Isotopes Completes Private Placement Of 8% Convertible Notes Due 2017 For US$3 Million 12
International Isotopes Inc, Key Competitors 13
International Isotopes Inc, Key Employees 14
International Isotopes Inc, Subsidiaries 15

★海外企業調査レポート[International Isotopes Inc (INIS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Catholic Medical Center:企業の戦略的SWOT分析
    Catholic Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • CK Infrastructure Holdings Ltd (1038):石油・ガス:M&Aディール及び事業提携情報
    Summary CK Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited, is an infrastructure investment company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure related …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Swedish Orphan Biovitrum AB (SOBI):製薬・医療:M&Aディール及び事業提携情報
    Summary Swedish Orphan Biovitrum AB (Sobi), formerly Biovitrum AB, is an integrated biopharmaceutical company that focuses on the development of products for the treatment of rare diseases. The company specializes in biotechnology with prime capabilities in protein biochemistry and biologics manufac …
  • Inova Health System:製薬・医療:M&Aディール及び事業提携情報
    Summary Inova Health System (Inova) is a non-profit health care system operating through multiple hospitals. It offers home health and long term care services, joint replacement services, liver disease services, mental health services, and neurosciences services among others. Through a network of ho …
  • T2 Biosystems Inc (TTOO):医療機器:M&Aディール及び事業提携情報
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • Molina Healthcare Inc:企業の戦略・SWOT・財務情報
    Molina Healthcare Inc - Strategy, SWOT and Corporate Finance Report Summary Molina Healthcare Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mangalore Refinery and Petrochemicals Ltd (MRPL):企業の財務・戦略的SWOT分析
    Mangalore Refinery and Petrochemicals Ltd (MRPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Cosmo Oil Co., Ltd.:企業の戦略・SWOT・財務分析
    Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • The Manufacturers Life Insurance Co:電力:M&Aディール及び事業提携情報
    Summary The Manufacturers Life Insurance Company (Manufacturers Life Insurance) is a financial service provider, based in Canada. The company provides financial protection, and wealth management products and services, and also asset management services to institutional customers. It offers individua …
  • Merck KGaA:企業のM&A・事業提携・投資動向
    Merck KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Hurricane Energy plc (HUR):企業の財務・戦略的SWOT分析
    Summary Hurricane Energy Plc (Hurricane) is an oil and gas exploration and development company that discovers and develops oil from fractured basement reservoirs. The company provides exploration properties such as lancaster basement prospect, whirlwind basement discovery, lincoln basement prospect, …
  • Biocodex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocodex Inc (Biocodex), a subsidiary of Biocodex, is a pharmaceutical company that manufacturs and distributs probiotic drug products. The company provides products such as Saccharomyces boulardii CNCM I-745 that has a positive effect on the gut's microflora. It also provides Florastor, a y …
  • Saudi Arabian Oil Co:企業の戦略的SWOT分析
    Saudi Arabian Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Latvenergo AS:電力:M&Aディール及び事業提携情報
    Summary Latvenergo AS (Latvenergo) is a state-owned power supply utility company that generates and supplies electricity and thermal energy, distributes electricity, leases transmission system assets. It generates electricity through various renewable energy sources such as hydropower, biomass, wind …
  • NW Natural Gas Co:企業の戦略的SWOT分析
    NW Natural Gas Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Paranta Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Paranta Biosciences Ltd (Paranta Biosciences) is a biopharmaceutical company that develops bio-therapeutics for the treatment of inflammatory and fibrotic diseases. The company develops product candidate PB01, a recombinant human follistatin-288 used for the treatment of cystic fibrosis lung …
  • All in West! Capital Corp:企業の戦略・SWOT・財務分析
    All in West! Capital Corp - Strategy, SWOT and Corporate Finance Report Summary All in West! Capital Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • JCDecaux SA:企業の戦略・SWOT・財務分析
    JCDecaux SA - Strategy, SWOT and Corporate Finance Report Summary JCDecaux SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Adhera Therapeutics (MRNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Adhera Therapeutics (Adhera) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using combination therapies of already approved drugs. The company is developing and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆